[Perinatal depression--recent topics].
Depression is the most common complication in perinatal period, affecting approximately 10% of women. Studies were also examined for data related to the predictors/risk factors, effects on the fetus and newborn, and treatment of depression during these periods. Psychopharmacological treatment in pregnant or breastfeeding women with depression will result primarily from a careful evaluation of their psychopathological condition. Maternal depression is associated with adverse effects on fetal and infant development. Prevention and psychological intervention is also useful for detecting mother with postnatal depression, using the EPDS. Controlled psychological trials for postnatal depression have shown the benefit of involving health professionals. Multidisciplinary specialist teams in mother and baby units have been an important role in perinatal psychiatric care.
Okano
Tadaharu
T
Centre for Health, Mie University.
D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D003863:Depression / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D019052:Depression, Postpartum / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D005260:Female; D006757:Hospital Units; D006760:Hospitalization; D006801:Humans; D007231:Infant, Newborn; D033261:Maternal-Fetal Relations; D009034:Mother-Child Relations; D011181:Postnatal Care; D011247:Pregnancy; D011248:Pregnancy Complications; D011295:Prenatal Care; D011613:Psychotherapy; D012307:Risk Factors
D000928:Antidepressive Agents